Michelle Fay Cortez
Bloomberg

August 27, 2021

People who recovered from a bout of Covid-19 during one of the earlier waves of the pandemic appear to have a lower risk of contracting the delta variant than those who got two doses of the vaccine from Pfizer Inc. and BioNTech SE.

The largest real-world analysis comparing natural immunity — gained from an earlier infection — to the protection provided by one of the most potent vaccines currently in use showed that reinfections were much less common. The paper from researchers in Israel contrasts with earlier studies, which showed that immunizations offered better protection than an earlier infection, though those studies were not of the delta variant. 

The results are good news for patients who already successfully battled Covid-19, but show the challenge of relying exclusively on immunizations to move past the pandemic. People given both doses of the Pfizer-BioNTech vaccine were almost six-fold more likely to contract a delta infection and seven-fold more likely to have symptomatic disease than those who recovered. 

Read more….

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *